Atomoxetine is the generic name for Strattera [1]. It is a selective norepinephrine reuptake inhibitor used to treat attention-deficit/hyperactivity disorder (ADHD) [2].
When did the patent for Strattera expire?
Eli Lilly and Company's patent for atomoxetine hydrochloride, the active ingredient in Strattera, expired, allowing generic versions to enter the market [3]. Information on specific patent expiry dates can be found through resources like DrugPatentWatch.com [4].
What are the differences between generic Strattera and brand-name Strattera?
Generic medications are required to be bioequivalent to their brand-name counterparts, meaning they contain the same active ingredient and should have the same therapeutic effect [5]. The primary differences are typically in inactive ingredients, such as fillers, binders, and colorants, which can affect appearance but not efficacy [5].
What are common side effects of atomoxetine?
Common side effects reported for atomoxetine include upset stomach, nausea, vomiting, fatigue, decreased appetite, dizziness, and mood swings [2]. Less common but potentially serious side effects can include liver problems, suicidal thoughts, and cardiovascular issues [2]. Patients should discuss any concerns with their healthcare provider.
Who manufactures generic atomoxetine?
Several pharmaceutical companies manufacture generic atomoxetine. These manufacturers typically enter the market after the brand-name drug's patents expire [4].
How does atomoxetine work to treat ADHD?
Atomoxetine works by increasing the levels of norepinephrine in the brain [2]. Norepinephrine is a neurotransmitter that plays a role in attention, impulse control, and hyperactivity [2]. By blocking the reuptake of norepinephrine, atomoxetine makes more of it available in the synaptic cleft, which is believed to improve ADHD symptoms [2].
Are there other medications for ADHD?
Yes, other medications are available for ADHD treatment, including stimulant medications like methylphenidate and amphetamines, as well as other non-stimulant options [6]. The choice of medication depends on individual patient needs, medical history, and response to treatment [6].
Where can I find more information on drug patents and generics?
Resources like DrugPatentWatch.com provide detailed information on drug patents, exclusivity periods, and the availability of generic alternatives for various medications [4].
What are the risks associated with atomoxetine?
Potential risks include liver injury, with symptoms like jaundice, dark urine, and abdominal pain requiring immediate medical attention [2]. There is also a boxed warning regarding suicidal thoughts and behaviors in children and adolescents [2]. Cardiovascular risks, such as increased blood pressure and heart rate, should also be monitored [2].
Sources:
1. https://www.drugpatentwatch.com/drug/strattera
2. https://www.mayoclinic.org/drugs-supplements/atomoxetine-oral-route/proper-use/drg-20075709
3. https://www.drugpatentwatch.com/content/articles/strattera-patent-expiration-and-generic-competition
4. https://www.drugpatentwatch.com/
5. https://www.fda.gov/drugs/generic-drugs/what-generic-drugs-are-and-how-they-may-save-you-money
6. https://www.additudemag.com/adhd-medication-list-stimulants-non-stimulants/